Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company's Balance Sheet UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) ("ProPhase" ...

Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance Sheet UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” ...

ProPhase Labs (PRPH) explores sale/partnership for BE-Smart esophageal cancer test and updates Crown Medical COVID claim recoveries.

ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET. The exclusive event, hosted by RedChip ...

UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH)と欧州のバイオテクノロジーグループAdvanced Biological Laboratories S.A. (ABL)は金曜日、ABLが合併後の企業の過半数所有者となるリバースマージャーに関する法的拘束力のない基本合意書を締結したと発表した。この発表は ...

ProPhase Labs' recent 52-week low is reflective of broader challenges faced by the company, as highlighted by several InvestingPro metrics and tips. The company's market capitalization stands at a ...

ProPhase Labs announced plans to launch DNA Complete and DNA Expand, scale up operations at PMI, and implement cost reduction plans. The company aims to reduce overhead costs by $6 million, which ...

ProPhase Labs, Inc. ('ProPhase” or the 'Company”), a diversified life sciences and diagnostics company, today announced that its common stock has been approved and uplisted from the Pink Sheets to the ...

Visit a quote page and your recently viewed tickers will be displayed here.